{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:42:08Z","timestamp":1761100928706},"reference-count":16,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,4,19]],"date-time":"2007-04-19T00:00:00Z","timestamp":1176940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Intravenous (IV) busulfan has been developed to overcome variable absorption of oral busulfan and tested in several trials. We tested its pharmacological properties and tolerability in 16 Korean stem cell transplantation (SCT) patients. IV busulfan was administered at 0.8\u2003mg\/kg every six h for a total of 16 doses (days \u22127 to \u22124), which was followed by cyclophosphamide administration at 60\u2003mg\/kg every 24\u2003h for two d (days \u22123 and \u22122). The median AUC<jats:sub>inf<\/jats:sub> values (at the first dose) and AUC<jats:sub>ss<\/jats:sub> (at the steady state) were 1060.4\u2003\u03bcM\u00b7min (range: 511.1\u20131812.7) and 1092.5 \u03bcM\u00b7min (range: 539.7\u20131560.8) respectively. All patients had an AUC<jats:sub>inf<\/jats:sub> of &lt;1500\u2003\u03bcM\u00b7min at the first dose, and 13 of the 16 (81.3%) maintained AUC<jats:sub>ss<\/jats:sub> levels between 800 and 1500\u2003\u03bcM\u00b7min. Thirteen of 16 patients showed successful engraftments but four patients (25%) developed hepatic VOD (two of which were fatal), three of whom had advanced disease at the time of SCT. Overall, pharmacokinetics of IV busulfan in our SCT patients appeared comparable with those observed in other study. However, hepatic VOD was a major morbidity in patients with advanced disease.<\/jats:p>","DOI":"10.1111\/j.1399-0012.2007.00664.x","type":"journal-article","created":{"date-parts":[[2007,5,3]],"date-time":"2007-05-03T18:17:36Z","timestamp":1178216256000},"page":"417-422","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation"],"prefix":"10.1111","volume":"21","author":[{"given":"Yo\u2010Han","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun\u2010Ae","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong yang","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Kook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung\u2010Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,19]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.7.2144.2144"},{"key":"e_1_2_6_3_2","first-page":"18","article-title":"Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens","volume":"20","author":"Grochow LB","year":"1993","journal-title":"Semin Oncol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.8.3055"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(00)70064-4"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2002.v8.pm11939604"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198603203141201"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198712000-00011"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(95)00054-M"},{"key":"e_1_2_6_10_2","first-page":"31","article-title":"Graft\u2010rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics","volume":"16","author":"Slattery JT","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1182\/blood.V95.4.1188.004k38_1188_1194","article-title":"Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66\u2003years of age","volume":"95","author":"Deeg HJ","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703264"},{"key":"e_1_2_6_13_2","first-page":"225","article-title":"Association of busulfan area under the curve with veno\u2010occlusive disease following BMT","volume":"17","author":"Dix SP","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-004-0982-4"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.12.4568"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-4-199302150-00003"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200212000-00013"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2007.00664.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2007.00664.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T22:55:01Z","timestamp":1696892101000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2007.00664.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,19]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1111\/j.1399-0012.2007.00664.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2007.00664.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,19]]}}}